Pain medication use disorder (PMUD): towards a new framework in pain management
Long-term pharmacological treatment of chronic non-cancer pain (CNCP) remains a persistent clinical dilemma, particularly regarding opioids and gabapentinoids. Despite limited evidence supporting their long-term use in CNCP, consumption of both drug classes remains high,[1][1] and their combined use
Authors
- Sam S. Eldabe (ORCID: https://orcid.org/0000-0002-9250-1886)
- Patrice Forget (ORCID: https://orcid.org/0000-0001-5772-8439)
- Cleo Lina Crunelle (ORCID: https://orcid.org/0000-0002-8798-0448)
- Lisa Bernaerts (ORCID: https://orcid.org/0000-0002-8279-657X)
- Lisa Goudman (ORCID: https://orcid.org/0000-0002-2271-9855)
- Bart Billet (ORCID: https://orcid.org/0000-0002-2841-0824)
- Dominic A. Hegarty (ORCID: https://orcid.org/0000-0002-8283-2198)
- Ali Jerjir
- Maarten Moens (ORCID: https://orcid.org/0000-0003-0577-5449)
- Michiel W. van Kernebeek (ORCID: https://orcid.org/0000-0001-9396-4471)
- Frenn Bultinck (ORCID: https://orcid.org/0000-0003-4176-6515)
- Elke Wuyts (ORCID: https://orcid.org/0000-0001-7322-4628)
- Louisa Degenhardt (ORCID: https://orcid.org/0000-0002-8513-2218)
- Ria Hopkins
Institutions
- Vrije Universiteit Brussel (BE)
- University of Aberdeen (GB)
- University College Cork (IE)
- James Cook University Hospital (GB)
- Research Foundation - Flanders (BE)
- UNSW Sydney (AU)
- Antwerp University Hospital (BE)
- Pain in Motion (BE)
- Universitair Ziekenhuis Brussel (BE)
- AZ Delta (BE)
Publication Details
- Journal
- Regional Anesthesia & Pain Medicine
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1136/rapm-2026-108555
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00